• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpyruvic acid derivatives

Recent Advances in Calcium Phenylpyruvate (51828-93-4) Research: A Comprehensive Review

Calcium Phenylpyruvate (CAS: 51828-93-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications and biochemical properties. This compound, a calcium salt of phenylpyruvic acid, has been studied for its role in metabolic pathways, particularly in relation to phenylketonuria (PKU) and other metabolic disorders. Recent studies have explored its efficacy in modulating enzymatic activity and its potential as a therapeutic agent in neurodegenerative diseases and cancer.

One of the key areas of focus in recent research is the compound's ability to act as a substrate or inhibitor in various enzymatic reactions. For instance, studies have demonstrated that Calcium Phenylpyruvate can influence the activity of phenylalanine hydroxylase (PAH), an enzyme critical in the metabolism of phenylalanine. This has implications for the treatment of PKU, where PAH dysfunction leads to the accumulation of phenylalanine, causing neurological damage. Preliminary findings suggest that Calcium Phenylpyruvate may help regulate phenylalanine levels, offering a novel approach to managing this condition.

In addition to its metabolic applications, Calcium Phenylpyruvate has been investigated for its potential anti-cancer properties. Recent in vitro studies have shown that the compound can induce apoptosis in certain cancer cell lines, particularly those associated with colorectal and breast cancers. The mechanism appears to involve the disruption of mitochondrial function and the generation of reactive oxygen species (ROS), leading to programmed cell death. These findings are promising, though further in vivo studies are needed to validate these effects and assess potential side effects.

Another emerging area of research is the use of Calcium Phenylpyruvate in neurodegenerative diseases. Studies have indicated that the compound may have neuroprotective effects, potentially slowing the progression of diseases such as Alzheimer's and Parkinson's. This is thought to be due to its ability to modulate oxidative stress and reduce inflammation in neural tissues. While these results are preliminary, they open new avenues for therapeutic development in neurology.

Despite these promising findings, challenges remain in the clinical application of Calcium Phenylpyruvate. Issues such as bioavailability, stability, and potential toxicity need to be addressed through further research. Recent advancements in drug delivery systems, such as nanoparticle encapsulation, may offer solutions to these challenges, enhancing the compound's therapeutic potential.

In conclusion, Calcium Phenylpyruvate (51828-93-4) represents a multifaceted compound with significant potential in metabolic, oncological, and neurological research. Continued investigation into its mechanisms of action and therapeutic applications is essential to fully realize its benefits. The integration of advanced drug delivery technologies and rigorous clinical trials will be critical in translating these findings into viable treatments.

• 156-06-9(a-Oxobenzenepropanoic Acid)
• 710-11-2(2-Oxo-4-phenylbutanoic Acid)
• 308075-13-0(Shortening)
• 17647-93-7(potassium 2-oxo-3-phenyl-propanoate)
• 61676-25-3(3-(3-methylphenyl)-2-oxopropanoic acid)
• 88768-11-0(5-Phenyl-2-Keto-Valeric Acid)
• 122049-54-1(Sodium 2-oxo-3-phenylpropanoate hydrate)
• 54865-40-6(Calcium PhenylpyruvateDISCONTINUED, See C145763)
• 61676-24-2(3-(2-Methylphenyl)-2-oxopropanoic acid)
• 114-76-1(Sodiumphenylpyruvate)